Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection

被引:19
作者
Aragones, Gerard [1 ]
Alonso-Villaverde, Carlos [2 ]
Oliveras-Ferraros, Cristina [3 ,4 ]
Beltran-Debon, Raul [1 ]
Rull, Anna [1 ]
Rodriguez-Sanabria, Fernando [1 ]
Camps, Jordi [1 ]
Vazquez Martin, Alejandro [3 ,4 ]
Menendez, Javier A. [3 ,4 ]
Joven, Jorge [1 ]
机构
[1] Univ Rovira & Virgili, Ctr Recerca Biomed, Hosp Univ St Joan, IISPV, E-43201 Reus, Spain
[2] Hosp Son Llatzer, Palma De Mallorca, Illes Balears, Spain
[3] Dr Josep Trueta Univ Hosp, ICO, Girona, Spain
[4] Dr Josep Trueta Univ Hosp, Biomed Res Inst IdIBGi, Girona, Spain
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DENSITY-LIPOPROTEIN CHOLESTEROL; HEPATITIS-C; INSULIN-RESISTANCE; CANCER; METABOLISM; BREAST; AMPK; ATHEROSCLEROSIS;
D O I
10.1186/1471-230X-10-92
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Fatty acid synthase (FASN) is an enzyme synthesized by the liver and plays an important role in lipogenesis. The present study aimed to investigate whether serum FASN concentration may provide a direct link between HIV and/or HCV viral infections and lipid metabolic disorders commonly observed in HIV/HCV-infected patients. Methods: We evaluated serum FASN concentration in 191 consecutive HIV-infected patients in the absence or presence of HCV co-infection. For comparison, 102 uninfected controls were included. Metabolic and inflammatory phenotype was also compared with respect to the presence of HCV co-infection. Results: Serum FASN concentration was significantly higher in HIV-infected patients than in healthy participants and HCV co-infected patients showed higher levels than those without co-infection. Levels were also affected by treatment regimen, but marginally influenced by virological variables. Insulin concentration was the sole variable among metabolic parameters that demonstrated a significant correlation with serum FASN concentrations. Serum alanine aminotransferase (ALT) values correlated significantly with serum FASN concentration and provided the best discrimination with respect to the presence or absence of HCV co-infection. In multivariate analysis, only ALT, monocyte chemoattractant protein-1 (MCP-1) and the presence of antiretroviral treatment regimen significantly contributed to explain serum FASN concentration in HIV/HCV co-infected patients. Conclusion: Serum FASN concentration is significantly increased in HIV-infected individuals. The release of FASN into the circulation is further enhanced in patients who are co-infected with HCV. Subsequent studies should explore the usefulness of this indicator to monitor the effect of viral infections on disease progression and survival.
引用
收藏
页数:10
相关论文
共 41 条
[1]   Insulin resistance and HIV infection: a review [J].
Aboud, M. ;
Elgalib, A. ;
Kulasegaram, R. ;
Peters, B. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (03) :463-472
[2]   Estrogen receptor-α mediates gender differences in atherosclerosis induced by HIV protease inhibitors [J].
Allred, KF ;
Smart, EJ ;
Wilson, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (03) :1419-1425
[3]   Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele [J].
Alonso-Villaverde, C ;
Coll, B ;
Parra, S ;
Montero, M ;
Calvo, N ;
Tous, M ;
Joven, J ;
Masana, L .
CIRCULATION, 2004, 110 (15) :2204-2209
[4]   Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome:: Dysregulated cell cycle progression and nuclear transport coincide with robust virus production [J].
Chan, Eric Y. ;
Qian, Wei-Jun ;
Diamond, Deborah L. ;
Liu, Tao ;
Gritsenko, Marina A. ;
Monroe, Matthew E. ;
Camp, David G., II ;
Smith, Richard D. ;
Katze, Michael G. .
JOURNAL OF VIROLOGY, 2007, 81 (14) :7571-7583
[5]   Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis [J].
Fisher, SD ;
Miller, TL ;
Lipshultz, SE .
ATHEROSCLEROSIS, 2006, 185 (01) :1-11
[6]   Activation of promoters for cellular lipogenic genes by hepatitis B virus large surface protein [J].
Foo, NC ;
Yen, TSB .
VIROLOGY, 2000, 269 (02) :420-425
[7]   Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome [J].
Grinspoon, S .
CLINICAL INFECTIOUS DISEASES, 2003, 37 :S85-S90
[8]   AMPK: a key regulator of energy balance in the single cell and the whole organism [J].
Hardie, D. G. .
INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (Suppl 4) :S7-S12
[9]   Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins [J].
Huang, Hua ;
Sun, Fang ;
Owen, David M. ;
Li, Weiping ;
Chen, Yan ;
Gale, Michael, Jr. ;
Ye, Jin .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (14) :5848-5853
[10]   Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions [J].
Kotler, Donald P. .
LIVER INTERNATIONAL, 2009, 29 :38-46